Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 88, Issue 2, Pages 144-153
Publisher
Wiley
Online
2011-10-04
DOI
10.1111/j.1600-0609.2011.01715.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
- (2011) M J Walter et al. LEUKEMIA
- Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS)
- (2009) Christina Economopoulou et al. ANNALS OF HEMATOLOGY
- Analysis of the Ten-Eleven Translocation 2 (TET2) gene in familial myeloproliferative neoplasms
- (2009) C. Saint-Martin et al. BLOOD
- Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)
- (2009) P. L. Greenberg et al. BLOOD
- Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
- (2009) T. E. Fandy et al. BLOOD
- Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
- (2009) A. M. Jankowska et al. BLOOD
- An assessment of erythroid response to epoetin α as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach
- (2009) Suneel Mundle et al. CANCER
- Novel TET2 Mutations Associated With UPD4q24 in Myelodysplastic Syndrome
- (2009) Azim M. Mohamedali et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
- (2009) A Tefferi et al. LEUKEMIA
- Many are called MDS cell lines: One is chosen
- (2009) Hans G. Drexler et al. LEUKEMIA RESEARCH
- Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells
- (2009) Madeleine P Ball et al. NATURE BIOTECHNOLOGY
- Acquired mutations in TET2 are common in myelodysplastic syndromes
- (2009) Saskia M C Langemeijer et al. NATURE GENETICS
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA methylation inhibits p53-mediated survivin repression
- (2009) N H Nabilsi et al. ONCOGENE
- Myelodysplastic syndromes: molecular pathogenesis and genomic changes
- (2008) Florian Nolte et al. ANNALS OF HEMATOLOGY
- AML1 mutations induced MDS and MDS/AML in a mouse BMT model
- (2008) N. Watanabe-Okochi et al. BLOOD
- Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
- (2008) Y. Jiang et al. BLOOD
- Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes
- (2008) Andrea Pellagatti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts
- (2008) G. J. Mufti et al. HAEMATOLOGICA
- Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms
- (2008) Olaf Hopfer et al. LEUKEMIA RESEARCH
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
- (2008) Benjamin L. Ebert et al. NATURE
- MDS: A Stem Cell Disorder--But What Exactly Is Wrong with the Primitive Hematopoietic Cells in This Disease?
- (2008) S. D. Nimer Hematology-American Society of Hematology Education Program
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started